We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

9 hedge funds and large institutions have $10.5K invested in Revelation Biosciences Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $6.76K → $10.5K (+$3.78K)

10.22% less ownership

Funds ownership: 22.02% → 11.8% (-10%)

18% less funds holding

Funds holding: 11 → 9 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PVI
Pine Valley Investments
New Jersey
+$2.25K
2
HF
HRT Financial
New York
+$202

Top Sellers

Rank Fund Capital Flow
1
Walleye Trading
Walleye Trading
New York
-$654
2
TSS
Two Sigma Securities
New York
-$72
3
Walleye Capital
Walleye Capital
New York
-$71
4
UBS Group
UBS Group
Switzerland
-$34
5
Citadel Advisors
Citadel Advisors
Florida
-$26

REVBW Hedge Fund Activity: Q1 2025 in Review

9 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2025, worth a combined $10.5K — up 56% from $6.76K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of REVBW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Pine Valley Investments, adding an estimated $2.25K. The largest seller was Walleye Trading, exiting entirely with an estimated $654 sold.

  • 9 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2025, down from 11 in Q4 2024.
  • Funds reported $10.5K of Revelation Biosciences Warrant stock for Q1 2025, up 56% quarter-over-quarter.
  • 1 fund opened new Revelation Biosciences Warrant positions in Q1 2025 and 3 closed out, a net change of -2 holders.
  • The largest Revelation Biosciences Warrant buyer in Q1 2025 was Pine Valley Investments, an estimated $2.25K added.
  • The largest Revelation Biosciences Warrant seller in Q1 2025 was Walleye Trading, an estimated $654 sold.

Based on aggregated 13F filings for Q1 2025.